|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 322.2 GBX | +0.70% |
|
-4.18% | +45.91% |
| 09/05 | Avon Protection wins UK MoD supply deal; Molten Ventures up | AN |
| 09/05 | Molten Ventures wins UK MoD supply contract | AN |
Oxford Biomedica plc reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was GBP 89.54 million compared to GBP 139.99 million a year ago. Net loss was GBP 157.49 million compared to GBP 39.16 million a year ago.
Basic loss per share from continuing operations was GBP 1.6311 compared to GBP 0.4129 a year ago. Diluted loss per share from continuing operations was GBP 1.6311 compared to GBP 0.4129 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +45.91% | 403M | |
| +6.64% | 111B | |
| +11.00% | 106B | |
| -12.93% | 22.24B | |
| +0.32% | 21.25B | |
| -4.36% | 18.97B | |
| -37.85% | 18.52B | |
| -11.19% | 16.81B | |
| +39.06% | 12.54B | |
| -25.38% | 8.09B |
OXFORD BIOMEDICA PLC 